Search Results 991-1000 of 14877 for Uvetils

  1. Mayo Clinic

    ... . VID-20115891. Home; Brightcove-Stroke Patient Story. Have 2X the impact! Give Today. The deadline to have twice the impact to advance healthcare ...

  2. A Study to Evaluate Preoperative Oral Microbiota-Based Investigational New Drug to Target Immune Response in Patients with Operable Stage I-III Breast Cancer - Mayo Clinic

    The primary purposes of this trial are to determine the safety and tolerability of RBX7455 given for at least 2 weeks and not more than 4 weeks prior to surgery ...

  3. Kidney Cancer Clinical Trials - Mayo Clinic Research

    Only 20% of cell-surface proteins have been investigated so far for drug development. Untargeted proteomics has been the gold standard to identify tumor- ...

  4. Dementia Clinical Trials - Mayo Clinic Research

    This project is focused on understanding the risk of cognitive impairment and dementia in total hip and total knee arthroplasty patients. It involves 4 aims:.

  5. A Study to Evaluate MYK-491 to Treat Patients with Primary Dilated Cardiomyopathy (DCM) Due to Genetic Variants - Mayo Clinic

    The purpose of this study is to establish safety and preliminary effectiveness of treatment with MYK-491 in patients with primary dilated cardiomyopathy (DCM) ...

  6. Vedolizumab Subcutaneous Long-Term Open-Label Extension Study - Mayo Clinic

    The purpose of this study is to obtain long term safety and tolerability data of vedolizumab subcutaneous (vedolizumab SC) in participants with ulcerative ...

  7. Study of CPI-0610 in Myelofibrosis (MF) - Clinical Trials

    This study aims to determine the efficacy of CPI-0610 + ruxolitinib compared with placebo + ruxolitinibin patients with naive myelofibrosis (MF). Participation ...

  8. In Vitro Studies in Cold Agglutinin Disease - Mayo Clinic

    The purpose of this study is to assess antibody activity IN vitro in cold agglutinin disease (CAD) patients. Participation eligibility. Participant eligibility ...

  9. Mayo Clinic

    The deadline to have twice the impact to advance healthcare research is May 15. Give Today.

  10. The LEADLESS II IDE Study (Phase II): A Safety and Effectiveness Trial for a Leadless Pacemaker System - Mayo Clinic

    Prospective, non-randomized, multi-center, international clinical study is designed to confirm the safety and effectiveness of the Aveir LP System in a subject ...